Invest in Israel Newsletter March 2010 Edition
VC Cafe
APRIL 8, 2010
billion, and in 2005 it bought another generics competitor, Ivax, based in Miami, for about $7.4 “Israel is known for its strong capabilities in technology and science. The acquisition of PBM adds another growth engine for Perrigo, which already has a 75% share of the store brand over the counter (OTC) drug market in the US.
68 
Let's personalize your content